Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Invested Capital (2018 - 2025)

Historic Invested Capital for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to $618.5 million.

  • Bicycle Therapeutics' Invested Capital fell 2557.7% to $618.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $618.5 million, marking a year-over-year decrease of 2557.7%. This contributed to the annual value of $793.1 million for FY2024, which is 11380.2% up from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Invested Capital is $618.5 million, which was down 2557.7% from $668.9 million recorded in Q2 2025.
  • Bicycle Therapeutics' 5-year Invested Capital high stood at $896.2 million for Q2 2024, and its period low was $142.0 million during Q2 2021.
  • Over the past 5 years, Bicycle Therapeutics' median Invested Capital value was $346.3 million (recorded in 2021), while the average stood at $429.3 million.
  • In the last 5 years, Bicycle Therapeutics' Invested Capital plummeted by 2931.84% in 2023 and then skyrocketed by 30719.18% in 2024.
  • Quarter analysis of 5 years shows Bicycle Therapeutics' Invested Capital stood at $346.3 million in 2021, then decreased by 21.8% to $270.8 million in 2022, then soared by 36.98% to $370.9 million in 2023, then surged by 113.8% to $793.1 million in 2024, then fell by 22.01% to $618.5 million in 2025.
  • Its last three reported values are $618.5 million in Q3 2025, $668.9 million for Q2 2025, and $740.3 million during Q1 2025.